Guizhou Yibai Pharmaceutical Co., Ltd. (600594.SS)
CNY 3.63
(1.4%)
CNY 3.63
(1.4%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 145.51 Million CNY | -43.45% |
| 2022 | 257.33 Million CNY | -52.0% |
| 2021 | 536.13 Million CNY | 10.19% |
| 2020 | 486.56 Million CNY | 28.8% |
| 2019 | 377.76 Million CNY | 148.56% |
| 2018 | -777.95 Million CNY | -266.83% |
| 2017 | 466.31 Million CNY | 0.51% |
| 2016 | 463.92 Million CNY | 138.48% |
| 2015 | 194.53 Million CNY | -62.88% |
| 2014 | 524.13 Million CNY | 6.32% |
| 2013 | 492.99 Million CNY | 29.39% |
| 2012 | 381.01 Million CNY | 22.63% |
| 2011 | 310.69 Million CNY | 41.63% |
| 2010 | 219.36 Million CNY | 62.32% |
| 2009 | 135.14 Million CNY | 15.79% |
| 2008 | 116.71 Million CNY | 66.06% |
| 2007 | 70.28 Million CNY | 148.71% |
| 2006 | -144.3 Million CNY | -333.2% |
| 2005 | 61.88 Million CNY | -6.96% |
| 2004 | 66.5 Million CNY | 8.82% |
| 2003 | 61.12 Million CNY | 13.6% |
| 2002 | 53.8 Million CNY | 46.93% |
| 2001 | 36.62 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -39.85 Million CNY | 38.47% |
| 2024 Q3 | -57.03 Million CNY | -43.12% |
| 2024 Q1 | -64.76 Million CNY | 3.19% |
| 2023 Q1 | 54.47 Million CNY | 108.7% |
| 2023 Q3 | 43.56 Million CNY | -56.98% |
| 2023 Q2 | 101.26 Million CNY | 85.88% |
| 2023 FY | 145.51 Million CNY | -43.45% |
| 2023 Q4 | -66.89 Million CNY | -253.56% |
| 2022 Q4 | -626.31 Million CNY | -1118.45% |
| 2022 Q3 | 61.49 Million CNY | -29.18% |
| 2022 Q2 | 86.83 Million CNY | 22.41% |
| 2022 FY | 257.33 Million CNY | -52.0% |
| 2022 Q1 | 70.93 Million CNY | 295.02% |
| 2021 Q2 | 120.67 Million CNY | 47.02% |
| 2021 Q1 | 82.08 Million CNY | 14.4% |
| 2021 FY | 536.13 Million CNY | 10.19% |
| 2021 Q4 | -36.37 Million CNY | -124.41% |
| 2021 Q3 | 149.01 Million CNY | 23.48% |
| 2020 Q1 | 72.73 Million CNY | 175.8% |
| 2020 Q3 | 99.66 Million CNY | 38.81% |
| 2020 Q4 | 71.75 Million CNY | -28.01% |
| 2020 FY | 486.56 Million CNY | 28.8% |
| 2020 Q2 | 71.79 Million CNY | -1.29% |
| 2019 Q4 | 26.37 Million CNY | -69.24% |
| 2019 Q1 | 78.39 Million CNY | 107.64% |
| 2019 Q3 | 85.73 Million CNY | 77.66% |
| 2019 FY | 377.76 Million CNY | 148.56% |
| 2019 Q2 | 48.25 Million CNY | -38.45% |
| 2018 Q1 | 122.15 Million CNY | 19.17% |
| 2018 Q4 | -1.02 Billion CNY | -2765.88% |
| 2018 Q2 | 87.86 Million CNY | -28.07% |
| 2018 Q3 | 38.5 Million CNY | -56.18% |
| 2018 FY | -777.95 Million CNY | -266.83% |
| 2017 Q4 | 102.51 Million CNY | -30.4% |
| 2017 FY | 466.31 Million CNY | 0.51% |
| 2017 Q3 | 147.27 Million CNY | 54.25% |
| 2017 Q2 | 95.47 Million CNY | -21.13% |
| 2017 Q1 | 121.04 Million CNY | 20.28% |
| 2016 Q4 | 100.63 Million CNY | -27.38% |
| 2016 FY | 463.92 Million CNY | 138.48% |
| 2016 Q1 | 97.4 Million CNY | 1015.55% |
| 2016 Q3 | 138.57 Million CNY | 8.84% |
| 2016 Q2 | 127.31 Million CNY | 30.71% |
| 2015 Q1 | 66.08 Million CNY | -63.1% |
| 2015 FY | 194.53 Million CNY | -62.88% |
| 2015 Q4 | 8.73 Million CNY | -92.47% |
| 2015 Q3 | 116.01 Million CNY | 3034.39% |
| 2015 Q2 | 3.7 Million CNY | -94.4% |
| 2014 Q4 | 179.12 Million CNY | 12.42% |
| 2014 Q1 | 62.14 Million CNY | -69.16% |
| 2014 FY | 524.13 Million CNY | 6.32% |
| 2014 Q2 | 123.53 Million CNY | 98.77% |
| 2014 Q3 | 159.33 Million CNY | 28.98% |
| 2013 FY | 492.99 Million CNY | 29.39% |
| 2013 Q4 | 201.48 Million CNY | 38.18% |
| 2013 Q3 | 145.82 Million CNY | 45.77% |
| 2013 Q1 | 45.64 Million CNY | -68.73% |
| 2013 Q2 | 100.03 Million CNY | 119.15% |
| 2012 Q3 | 116.09 Million CNY | 42.61% |
| 2012 FY | 381.01 Million CNY | 22.63% |
| 2012 Q1 | 37.54 Million CNY | -67.36% |
| 2012 Q2 | 81.4 Million CNY | 116.8% |
| 2012 Q4 | 145.96 Million CNY | 25.72% |
| 2011 Q1 | 21.49 Million CNY | -61.04% |
| 2011 Q3 | 97.27 Million CNY | 26.49% |
| 2011 Q4 | 115.02 Million CNY | 18.25% |
| 2011 Q2 | 76.9 Million CNY | 257.8% |
| 2011 FY | 310.69 Million CNY | 41.63% |
| 2010 Q4 | 55.16 Million CNY | -21.63% |
| 2010 Q1 | 30.12 Million CNY | -31.83% |
| 2010 FY | 219.36 Million CNY | 62.32% |
| 2010 Q2 | 63.68 Million CNY | 111.38% |
| 2010 Q3 | 70.38 Million CNY | 10.53% |
| 2009 Q4 | 44.19 Million CNY | 18.3% |
| 2009 Q3 | 37.35 Million CNY | -10.79% |
| 2009 Q2 | 41.87 Million CNY | 257.64% |
| 2009 Q1 | 11.7 Million CNY | -50.61% |
| 2009 FY | 135.14 Million CNY | 15.79% |
| 2008 Q4 | 23.7 Million CNY | -32.7% |
| 2008 FY | 116.71 Million CNY | 66.06% |
| 2008 Q1 | 21.82 Million CNY | -8.66% |
| 2008 Q2 | 35.96 Million CNY | 64.77% |
| 2008 Q3 | 35.22 Million CNY | -2.05% |
| 2007 Q1 | 5.32 Million CNY | 103.2% |
| 2007 Q2 | 22.13 Million CNY | 315.64% |
| 2007 FY | 70.28 Million CNY | 148.71% |
| 2007 Q4 | 23.89 Million CNY | 26.21% |
| 2007 Q3 | 18.93 Million CNY | -14.48% |
| 2006 Q2 | 14.98 Million CNY | 13414.55% |
| 2006 Q1 | -112.56 Thousand CNY | -100.26% |
| 2006 Q4 | -166.39 Million CNY | -2405.79% |
| 2006 Q3 | 7.21 Million CNY | -51.85% |
| 2006 FY | -144.3 Million CNY | -333.2% |
| 2005 Q4 | 42.87 Million CNY | 438.27% |
| 2005 FY | 61.88 Million CNY | -6.96% |
| 2005 Q1 | 577.84 Thousand CNY | -98.44% |
| 2005 Q2 | 10.46 Million CNY | 1710.68% |
| 2005 Q3 | 7.96 Million CNY | -23.87% |
| 2004 Q1 | 6.82 Million CNY | 0.0% |
| 2004 Q3 | 7.8 Million CNY | -47.58% |
| 2004 Q2 | 14.88 Million CNY | 118.05% |
| 2004 FY | 66.5 Million CNY | 8.82% |
| 2004 Q4 | 37 Million CNY | 374.29% |
| 2003 FY | 61.12 Million CNY | 13.6% |
| 2002 FY | 53.8 Million CNY | 46.93% |
| 2001 FY | 36.62 Million CNY | 0.0% |